Selective Estrogen Receptor Degraders
- Name
- Selective Estrogen Receptor Degraders
- Accession Number
- DBCAT005805
- Description
Not Available
- Drugs
Drug Drug Description Elacestrant An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. - Drugs & Drug Targets
Drug Target Type Elacestrant Estrogen receptor alpha target Elacestrant Cytochrome P450 3A4 enzyme Elacestrant Cytochrome P450 2A6 enzyme Elacestrant Cytochrome P450 2C9 enzyme Elacestrant Solute carrier organic anion transporter family member 2B1 transporter Elacestrant P-glycoprotein 1 transporter Elacestrant ATP-binding cassette sub-family G member 2 transporter